Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine

First line treatment for pancreatic cancer consists of surgical resection, if possible, and a subsequent course of chemotherapy using the nucleoside analogue gemcitabine. In some patients, an active transport mechanism allows gemcitabine to enter efficiently into the tumor cells, resulting in a sign...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Quinn, Bridget A., Wang, Si, Barile, Elisa, Das, Swadesh K., Emdad, Luni, Sarkar, Devanand, De, Surya K., Kharagh, Susan Morvaridi, Stebbins, John L., Pandol, Stephen J., Fisher, Paul B., Pellecchia, Maurizio
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4941374/
https://ncbi.nlm.nih.gov/pubmed/26959746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.7931
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars